Skip to main content
Download PDF
Download ePub

Biological effects of carbon black nanoparticles are changed by surface coating with polycyclic aromatic hydrocarbons

Particle and Fibre Toxicology volume 14, Article number: 8 (2017) Cite this article

Abstract

Background

Carbon black nanoparticles (CBNP) are mainly composed of carbon, with a small amount of other elements (including hydrogen and oxygen). The toxicity of CBNP has been attributed to their large surface area, and through adsorbing intrinsically toxic substances, such as polycyclic aromatic hydrocarbons (PAH). It is not clear whether a PAH surface coating changes the toxicological properties of CBNP by influencing their physicochemical properties, through the specific toxicity of the surface-bound PAH, or by a combination of both.

Methods

Printex®90 (P90) was used as CBNP; the comparators were P90 coated with either benzo[a]pyrene (BaP) or 9-nitroanthracene (9NA), and soot from acetylene combustion that bears various PAHs on the surface (AS-PAH). Oxidative stress and IL-8/KC mRNA expression were determined in A549 and bronchial epithelial cells (16HBE14o-, Calu-3), mouse intrapulmonary airways and tracheal epithelial cells. Overall toxicity was tested in a rat inhalation study according to Organization for Economic Co-operation and Development (OECD) criteria. Effects on cytochrome monooxygenase (Cyp) mRNA expression, cell viability and mucociliary clearance were determined in acute exposure models using explanted murine trachea.

Results

All particles had similar primary particle size, shape, hydrodynamic diameter and ζ-potential. All PAH-containing particles had a comparable specific surface area that was approximately one third that of P90. AS-PAH contained a mixture of PAH with expected higher toxicity than BaP or 9NA. PAH-coating reduced some effects of P90 such as IL-8 mRNA expression and oxidative stress in A549 cells, granulocyte influx in the in vivo OECD experiment, and agglomeration of P90 and mucus release in the murine trachea ex vivo. Furthermore, P90-BaP decreased particle transport speed compared to P90 at 10 μg/ml. In contrast, PAH-coating induced IL-8 mRNA expression in bronchial epithelial cell lines, and Cyp mRNA expression and apoptosis in tracheal epithelial cells. In line with the higher toxicity compared to P90-BaP and P90-9NA, AS-PAH had the strongest biological effects both ex vivo and in vivo.

Conclusions

Our results demonstrate that the biological effect of CBNP is determined by a combination of specific surface area and surface-bound PAH, and varies in different target cells.

Background

The toxicity of nanoparticles is thought to be determined by their surface reactivity, influenced in turn by their chemical composition, physical properties and surface chemistry [1–8]. Carbon black nanoparticles (CBNP) are composed mainly of carbon with a small amount of other elements (including hydrogen and oxygen), and in themselves are nontoxic. However, CBNP are potentially harmful since their large surface area can interact with biological systems [1, 9–14]. Furthermore, substances such as polycyclic aromatic hydrocarbons (PAHs) that are intrinsically toxic can be adsorbed during CBNP synthesis [15]. The theory that the toxicity of CBNP can be increased by other substances has been validated by the application of metal ions, which increased the toxicity due to autophagy and lysosomal dysfunction [16]. However, it is still not clear how direct binding of chemical add-ons to CBNP modifies their interaction with biological systems [5, 17–19]. Several outcomes are theoretically possible. First, binding of chemicals to the particle surface can modify the surface properties of CBNP, reducing the surface area, thereby potentially reducing toxicological effects [1]. Second, the toxicity of the bound substances can determine the overall toxicity of the resulting particles [20]. Third, the modification could lead to a new particle type, whose biological activity might be a combination of changed physicochemical properties and the toxicity of the bound substances.

A common surface modification of CBNP is the adsorption of PAHs, occurring during incomplete combustion [21]. PAHs are thought to be mutagenic and carcinogenic, generally after toxification by cytochrome P450 enzymes (Cyp), and therefore are regarded as lung tumor inducing substances, although with only very limited acute toxicity [15, 22, 23]. Despite this limited acute toxicity, their effect on biological systems can be easily monitored by their potential to induce specific Cyp enzymes.

Compared with unmodified CBNP, surface modification of CBNP with PAHs has not shown increased tumor induction either following long-term exposure [24] or in cell lines in terms of cytokine release, induction of single and double strand breaks, cell cycle arrest, or phosphorylation of p53 or histone [25–27]. This suggests that PAHs have limited toxic effects when bound to CBNP, supporting the theory that they are not biologically available in this state [28] and that surface modification has a minor effect on the overall toxicity of CBNP.

However, diesel exhaust particles that contain PAHs are associated with an increased risk of asthma, and experiments involving exposure of a bronchial cell line to ultrafine particles implied a role of PAH in their toxic effects [29–31]. Furthermore, removal of PAHs from these exhaust particles resulted in reduced carcinogenic potential [24]. These data suggests that the effect of PAHs on the behavior of CBNP in biological systems is more complex.

Since inhalation is the predominant route of exposure to CBNP, we tested the toxicity of particles in different test systems including cell cultures, ex vivo studies on excised airways, and an in vivo inhalation study conducted according to Organization for Economic Co-operation and Development (OECD) criteria [32]. Initially, we tested the CBNP in high-throughput cell culture systems that can predict the toxicity of particles, and which therefore allowed us to preselect CBNP for in vivo testing. We then analyzed the in vivo effects of the selected CBNP in inhalation studies, and then finally tested the CBNP in ex vivo airway preparations to determine their impact on ciliary beat frequency, particle transport speed and mucus appearance. In every test system we analyzed parameters that indicate CBNP-induced oxidative stress and IL-8 response.

This allowed us to compare specific toxicological effects in each system to gain a more comprehensive insight into the cellular effects of the particles.

Methods

To understand how surface modification can change the interaction of CBNP with biological systems we used PAHs to modify the surface of a toxicologically well-defined CBNP, Printex®90 (P90). This is characterized by a high surface area and has been widely used in toxicological studies, resulting in only minor toxic effects [1, 33, 34].

For modification of the P90 surface, we used benzo[a]pyrene (BaP) and 9-nitroanthracene (9NA). BaP was chosen because of the well characterized toxicity of its metabolites, which are known to induce ROS and DNA adducts [23, 35–38]. BaP is known to induce Cyp1A1 and 1B1, which then metabolize BaP to toxic metabolites; this therefore allows monitoring of BaP activity and its biological effect [39, 40]. In contrast, 9NA is a PAH that occurs during combustion, and is regarded as a low toxicity PAH, as predicted by the Ames test and human cell mutagenicity assay [41–43]. However, due to its nitro group other toxic mechanisms can occur induced by intermediates resulting from reduction of the nitro group [41]. As coating of a particle does not necessarily represent the situation found in nanoparticles that acquire PAH during synthesis, we also generated CBNP by acetylene combustion [44]. The resulting acetylene soot (AS) had a mixture of PAHs on the surface (AS-PAH). In the suspensions we used, AS-PAH had a slightly larger specific surface area, but similar aggregate size and ζ-potential compared to PAH-coated P90, The physicochemical parameters of the different particles were evaluated by a variety of analytic test methods (see Tables 1, 2 in the Results section and Additional files 1, 2).

Particle synthesis and characterization

Modification of CBNP

80 g of unmodified P90 (Evonik Carbon Black GmbH, Frankfurt, Germany) together with 20 g of BaP (Thermo Fisher Scientific-Alfa Aesar, Heysham, Lancashire, UK) or 9NA (Merck Schuchardt OHG, Hohenbrunn, Germany) were suspended in 100 ml dimethyl ether and incubated in an ultrasonic bath at room temperature for 15 min. After subsequent vacuum desiccation, the coated P90 nanoparticles were stored at room temperature.

Gas phase synthesis of AS-PAH

A flat flame burner in a low pressure combustion chamber with acetylene as the fuel was used for the synthesis of AS-PAH. The experiments were carried out with a carbon to oxygen ratio of 1.1 to 1. The laminar mass flow of acetylene was set via mass flow controllers (Brooks 5850E; Brooks Instruments, Hatfield, PA, USA) on 88 ln/h with the oxygen mass flow adjusted to 80 ln/h. Temperature and pressure were monitored by a thermocouple and a pressure sensor, with the pressure set to 70 mbar during synthesis. The AS-PAH was collected for 60 min on a filter (Gore Membrane Filter Bags) between the combustion chamber and the rotary vane pump (TRIVAC D 65 B; Oerlikon Leybold Vakuum, Cologne, Germany).

Particle size distribution

The particle size distributions were measured by scanning electron microscopy (SEM; Leo 1530; LEO Electron Microscopy Inc., Thornwood, NY, USA) and transmission electron microscopy (TEM; CM200 FEG/ST, Philips, Amsterdam, Netherlands). The PAHs on the particle surface had to be extracted with toluene prior to electron microscopy, as otherwise they would be cracked by the beam and the particles would grow. Remaining CBNP were then suspended with acetone in an ultrasonic bath, and the suspension was applied thinly using an ultrasonic nebulizer, either to a silicon wafer (for SEM) or to a 400 mesh cooper grid (Ted Pella, Inc., Redding, CA, USA) (for TEM). The diameter of 200 particles of 5 images was determined with the program ImageJ. A log normal curve was fitted on the particle size distribution to get the average particle diameter.

Thermal analysis

The thermal release of coated PAHs from P90 and of volatile substances from AS-PAH was investigated using a thermogravimetric analyzer (DuPont 951; DuPont Company, Wilmington, DE, USA) connected to a quadrupole mass spectrometer (QMG 420; Balzers AG, Balzers, Liechtenstein) through a differentially pumped inlet system. The transfer line between the thermobalance and the mass spectrometer was heated up to 400 °C to prevent condensation of the pyrolysis products. The experiments were performed with sample sizes of 5–10 mg at a heating rate of 10 °C/min up to a final temperature of 800 °C at a helium flow rate of 100 ml/min. Each sample was measured at least three times.

Identification of PAHs on AS-PAH surface

To characterize the PAHs on the particle surfaces, CBNP samples were heated under dynamic conditions. A sample of 100 mg was heated up in an oven in 10 °C/min increments to vaporize the PAHs, with the volatile PAHs collected in a cold trap. The condensed products were dissolved in 5 ml toluene, and were characterized by a standard gas chromatograph-mass spectrometer (GC/MS-QP 2010SE; Shimadzu Corporation, Tokyo, Japan). The chromatographic parameters for GC/MS were: Phenomenex zb-5msi column (column length: 30 m; I.D.: 0.25 mm; film thickness 0.25 mm); injector temperature 250 °C; oven temperature program: 65 °C at 5 min constant, 10 °C min to 350 °C at 10 min constant.

Specific surface area

The surface area was determined by Brunauer, Emmett and Teller (BET) measurement using a BelSorp II device (BelJapan, Inc., Osaka, Japan), using the BelSorp analysis program.

Particle size and ζ-potential in suspension

Suspensions were prepared with 10 mg of sample plus 100 ml of double-deionized water. To keep the suspension stable, 500 mg of bovine serum albumin (BSA) (AppliChemInc., Maryland Heights, MO, USA) was added. The suspensions were treated with an ultrasonic homogenizer (Sonoplus, Rod: VS 70 D; Bandelin electronic GmbH & Co. KG, Berlin, Germany) for 40 min in pulse mode, changing 20 times between 30 s ultrasonic and 90 s resting interval. To avoid thermal denaturation of BSA, the suspensions were cooled in a beaker containing ice water during treatment. The particle size measurements were carried out as soon as the suspension had reached room temperature using a Malvern ZetaSizer Nano-ZS (Malvern Instruments Ltd, Worcestershire, UK). Particle size was quantified by dynamic light scattering, and ζ-potential was measured by laser Doppler microelectrophoresis using the Smoluchowski model. The index of refraction and the absorption were preset at 2.0 in the measurement software (DTS Nano; Malvern Instruments Ltd, Worcestershire, UK). The cuvettes to measure the particle size distribution and the ζ-potential were washed using double-deionized water and ethanol (70%) to remove potential impurities. Subsequently, the cuvettes were rinsed using approximately 2 ml of the sample, and were then filled with the sample and placed in the Zetasizer Nano-ZS. The suspensions were characterized in triplicates, and the means and standard derivations were calculated.

Endotoxin tests

CBNP suspensions were tested for endotoxins using the CROMO-LAL assay (Associates of Cape Cod Inc., East Falmouth, MA, USA) according to the manufacturer’s protocol. The limit of detection was 0.005 EU/ml (comparable to 0.5 pg/ml endotoxin of E. coli Type 055:B5). The suspensions were only used for experiments if no endotoxins were detected.

Experiments with human pulmonary cell lines

Cell culture

We used A549 cells (DSMZ, Braunschweig, Germany), 16HBE14o- cells (University California, San Francisco, USA; described in [45]) and Calu-3 cells (American Type Culture Collection, Manassas, VA, USA). The epithelial cells were cultured in Dulbecco’s modified eagle’s medium (DMEM) with 10% fetal calf serum (FCS) and 0.1% gentamicin for ROS and transepithelial electrical resistance (TEER) measurements. For mRNA expression analysis, A549 cells were cultured in DMEM (Fisher Scientific GmbH, Schwerte, Germany) with 10% FCS and 0.1% gentamicin, 16HBE14o- cells were cultured in DMEM (Biochrom AG, Berlin, Germany) with 10% FCS (PAA Laboratories GmbH, Cölbe, Germany) 1% L-glutamine (Gibco™, Life Technologies GmbH, Darmstadt, Germany) and 1% penicillin/streptomycin (Sigma Aldrich Chemie GmbH, Taufkirchen, Germany), and Calu-3 cells were cultured in RPMI 1640 containing stable glutamine supplemented with 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomycin (all from Biochrom AG, Berlin, Germany). Cells were kept in a 37 °C humidified atmosphere containing 5% CO2.

Flow cytometric measurements of reactive oxygen species (ROS)

Cells were seeded in T25 flasks (PAA Laboratories GmbH, Cölbe, Germany), at 0.6 × 106 for A549 cells and at 1 × 106 for 16HBE14o- cells. Subconfluent cultures were exposed to CBNP at a concentration of 10 μg/ml or 50 μg/ml for 24 h. The culture medium was subsequently removed and the cell monolayers were washed twice with 5 ml pre-warmed phosphate buffered saline (PBS). The fluorescent dye dichloro-dihydro-fluorescein diacetate (DCFH-DA) was applied to the cells in 5 ml fresh medium, with the resulting mixture incubated for 30 min at 37 °C. The culture medium was then removed and the cells were washed twice with 5 ml pre-warmed PBS and harvested by trypsinization. Flow cytometry measurements were done with a FACScan cytometer (Becton Dickinson Biosciences, San Jose, CA, USA) equipped with a 488 nm argon laser, with CELLQuest™ software used for data acquisition. For each sample, 10,000 events were analyzed and fluorescence emission of dichlorofluorescein (DCF) was examined at 530 nm.

Quantitative RT-PCR

A549 cells were seeded in T25 flasks at 0.6 × 106. Calu-3 cells and 16HBE14o- cells were seeded in 12-well plates (Costar, Corning, NY, USA) at 5 × 105 cells and 1.6 × 105 cells, respectively. After reaching a confluency of ≥90%, culture medium was exchanged and cells were treated with CBNP at 10 μg/ml, 50 μg/ml or medium/BSA alone for 24 h. Subsequently, cells were washed twice with pre-warmed medium or PBS to remove particles, and total RNA was extracted from Calu-3 cells using a NucleoSpin RNA Kit (Macherey-Nagel, Düren, Germany) and from A549 and 16HBE14o- cells using a RNeasy Kit (Quiagen GmbH, Hilden, Germany) according to the manufacturers’ instructions.

Reverse transcription was performed for RNA of A549 cells with the Omniscript Kit (Quiagen GmbH, Hilden, Germany), of 16HBE14o- cells using MaximaFirstStrand cDNA synthesis (Fermentas/Life Technologies GmbH, Darmstadt, Germany), and of Calu-3 cells using Oligo(dT)12–18 and Superscript III reverse transcriptase (Thermo Fisher Scientific, Waltham, USA), all according to the manufacturers’ protocols.

To quantify IL-8 and hypoxanthine-guanine phosphoribosyltransferase (HPRT) mRNA levels in A549 cell preparations, we used Viiaâ„¢7 (Life Technologies GmbH, Darmstadt, Germany); for preparations of 16HBE14o- and Calu-3 cells, we used LightCycler 480 SYBR green I Master (Roche Applied Science, Mannheim, Germany).

The sequences of used IL-8 primers and housekeeping gene HRPT1 primers are shown in Additional file 3. The housekeeping gene was evaluated with GenEx software (MultiD Analyses AB, Gothenburg, Sweden) [46]. The quality of amplificates was tested by melting curve analysis. The n-fold change was calculated for A549 cells with the program GenEx (GenEx Professional 5.4.3 Software), and by normalization of relative expression data to medium control data for 16HBE14o- and Calu-3 cells.

Measurement of the transepithelial electrical resistance (TEER)

A total of 2 × 105 Calu-3 cells were seeded per well on Transwell® filter inserts (polyester, 12-well plates, 12 mm diameter, 0.4 μm pore size; Corning Costar, Bodenheim, Germany) and cultivated for 9 days. On day 10, the cell monolayers were exposed to CBNP at 10 μg/ml or 50 μg/ml for 24 h. The culture medium was changed and the cells were incubated for at least 15 min at 37 °C, before TEER was measured using an EVOM volt-ohm-meter (World Precision Instruments, Sarasota, Fl, USA).

Statistical analysis

Differences between untreated controls and treated cultures were considered statistically significant at p < 0.05. Flow cytometric and TEER data were analyzed by two-sided Student’s t-test for unpaired values using Microsoft Excel. Relative mRNA expression results were analyzed by Mann Whitney U test.

Nose-only inhalation study in rats

Animals

Male Wistar rats (strain Crl:WI (Han)) were purchased from Charles River Deutschland (Sulzfeld, Germany). The age of the animals was 10 to 11 weeks and the weight 285 ± 24 g (mean ± SD) at the onset of exposure. Rats were exposed to the test item by nose-only inhalation. For 3 weeks prior to exposure, animals were trained to become accustomed to nose-only tubes. The OECD inhalation study on rats was approved by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (33.14 42502-04013/1199).

Study design and dosing scheme

The CBNP were administered to the test animals by nose-only inhalation. P90, P90-BaP and AS-PAH were tested; P90-9NA was not administered, given the previously described low toxicity [41–43] and the in vitro tests in this study. A nominal aerosol concentration of 6 mg/m3 was used, with exposure of 6 h/day for two weeks (no exposure on weekends) according to the OECD criteria for acute exposure [32]. CBNP-related effects on innate immune cells in the bronchoalveolar lavage (BAL) and histopathological changes in lung tissue were analyzed on day 1 and day 14 after cessation of exposure. Potassium bromate (KBrO3) treated animals (250 mg/kg in physiological saline, intraperitoneal) served as positive controls for Comet-assay. The animals were treated with KBrO3 on day 1 and day 14. BAL was collected and analyzed 3 h after application.

Bronchoalveolar lavage and leukocyte determination

BAL was performed in five rats per group after the end of exposure (day 1) and following a 14-day recovery period. Following preparation, lungs were lavaged with saline using two lavages of 5 ml each. The lavage fluid was collected in calibrated tubes and the harvested volume was recorded. Leukocyte concentration was determined using a counting chamber, and two cytoslides were prepared with a cytocentrifuge (Shandon Co., Frankfurt, Germany) for differential cell counts (macrophages, granulocytes, lymphocytes). The slides were air dried, and the cells were stained with Diffquick solutions (Medion Grifols Diagnostics AG, Düdingen, Switzerland) and counted. The results are presented as percentage of the total number of BAL cells.

Statistical analysis

Differences between BAL analysis groups were considered statistically significant at p < 0.05. Data were analyzed using analysis of variance. If the group means differed significantly by the analysis of variance the means of the treated groups were compared with the means of the control groups using Dunnett’s test.

Experiments with explanted mouse trachea

Particle suspension in cell culture medium

For the ex vivo studies we used CBNP concentrations of 10 and 30 μg/ml. The concentration of 30 μg/ml was calculated by surface correction of the in vitro concentration.

The CBNP suspensions were diluted in DMEM (Gibco™, Life Technologies GmbH, Darmstadt, Germany) with 20 mM HEPES, 1% penicillin/streptomycin (Sigma Aldrich Chemie GmbH, Taufkirchen, Germany) and 2 mM L-glutamine (Life Technologies GmbH, Darmstadt, Germany) for incubation of tracheae.

Animals

We used 8 to 12 week old female Balb/c mice (Charles River Laboratories, Sulzfeld, Germany). Mice were euthanized with an overdose of isoflurane for explantation of the trachea. The ex vivo studies on mouse tracheae were approved by the Ministerium für Landwirtschaft, Umwelt und ländliche Räume des Landes Schleswig-Holstein.

Preparation and culture conditions of explanted trachea

Tracheae were explanted and transferred to culture dishes coated with a thin layer of Sylgard polymer and filled with medium. Each trachea sample was fixed on the bottom of a well with an insect needle, covered with 1 ml of medium with or without suspended CBNP and incubated at 37 °C for 24 h.

Qualitative RT-PCR

To examine differences in mRNA expression levels, tracheae were cut into two pieces. One piece was incubated for 24 h with particle suspension; the other piece was incubated in medium only, serving as negative control. The epithelium was then removed using a sterile swab (Collection Swab H268A; Copan diagnostic, Inc., Murrieta, CA, USA). This isolation method was previously described in [47]. The RNA was isolated with innuPREP RNA isolation Kit (Analytic Jena AG, Jena, Germany) according to the manufacturer’s protocols. Any remaining DNA was enzymatically degraded using Amplification Grade DNase I kit AMPD-1 (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). The quality and quantity of isolated mRNA was analyzed with a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The mRNA was subsequently transcribed to cDNA using RevertAid H Minus Reverse Transcriptase (Fisher Scientific-Germany GmbH, Schwerte, Germany) mixed in transcription buffer with dNTPs (0.6 mM) (Fisher Scientific-Germany GmbH, Schwerte, Germany), DTT (10 mM) (Life technologies GmbH, Darmstadt, Germany) and random hexamer primers (17.5 ng/μl) (Biomers.net GmbH, Ulm, Germany).

Real time RT-PCR was performed in TaqMan Universal PCR Master Mix (Life technologies GmbH, Darmstadt, Germany), with probes tagged with reporter 6-FAM and quencher Tamra. The TaqMan probes and primers used for quantitative real time RT-PCR are shown in Additional file 3. The PCR program was: one cycle at 95 °C for 10 min followed by 50 cycles at 95 °C for 45 s and at 60 °C for 1 min. Changes in the transcript levels were determined by calculating the difference in cycle threshold to the respective negative control with the ΔΔCt method and represented as n-fold expression (2 −ΔΔCt).

Apoptosis and necrosis assays

Tracheae were explanted, incubated in pre-warmed medium, opened and cut in four equal parts. One part was cultured in medium alone, two parts were incubated for 24 h with CBNP suspensions of 10 μg/ml and 30 μg/ml, respectively, and the remaining parts were incubated for 24 h with 1 μM staurosporine (Roche Diagnostics GmbH, Mannheim, Germany) or 1 mM paraquat (Sigma-Aldrich GmbH, Seelze, Germany), respectively as positive controls for the staining procedure.

For the apoptosis analysis, whole mount samples of tracheae were fixed with phosphate buffered 4% paraformaldehyde (pH 7.4), followed by washing with PBS (pH 7.4) and permeabilization with ice cold acetone. The specimens were then incubated overnight at room temperature with rabbit anti-cleaved caspase-3 antibody (#9661, dilution 1:300, Cell Signaling Technology Inc., Danvers, MA, USA). The primary antibody was detected using Alexa555-conjugated donkey anti-rabbit IgG (dilution 1:800, Life Technologies GmbH, Darmstadt, Germany).

For membrane damage analysis, ethidium homodimer-1 (1 μg/ml, Life Technologies GmbH, Darmstadt, Germany) in medium was added to the trachea preparation, and was then incubated for 30 min at 37 °C. The samples were fixed with 4% paraformaldehyde (pH 7.4), washed with PBS (pH 7.4) and permeabilized with acetone.

To identify the epithelial layer, ciliated cells were labeled with a mouse monoclonal antibody against acetylated α-tubulin (Clone 6-11B-1, Sigma-Aldrich GmbH, Steinheim, Germany) that was directly labeled with Atto488 (Lightning-Link™Atto488 conjugation kit; Innova Bioscience Ltd., Cambridge, UK); cell nuclei were visualized using Hoechst 33258 (0.1 μg/ml; Sigma-Aldrich, Steinheim, Germany) (Additional file 4).

Apoptosis and cell membrane damage were analyzed using a confocal laser scanning microscope (LSM 510 Meta; Carl Zeiss MicroImaging GmbH, Göttingen, Germany) equipped with a Plan-Apochromat 20×/0.75 or C-Apochromat 40×/1.2 W objective. The total number of apoptotic and necrotic epithelial cells was counted in the complete whole mount preparation.

Ciliary beat frequency and cilia-driven particle transport

Tracheae were transferred to a Delta T4 Culture dish (Bioptechs Inc., Butler, PA, USA), the bottom of which was covered with sylgard polymer. Samples were fixed with insect needles with the epithelium facing upwards, and were then covered with 2 ml of HEPES-Ringer solution. The temperature of HEPES-Ringer solution was maintained at 30 °C using a Bioptechs Delta T4 Culture Dish Controller (Bioptechs Inc., Butler, PA, USA), and the epithelial surface was imaged using a Zeiss Axioskop 2 FS fixed stage microscope equipped with Achroplan 40×/0.80 W or 20×/0.50 W objectives (Carl Zeiss MicroImaging GmbH, Göttingen, Germany).

Polystyrene particles (4.5 μm) were added to the HEPES-Ringer solution with a concentration of 2 × 106 particles/ml. The transport of particles was recorded with a SMX-150 M camera (EHD Imaging GmbH, Damme, Germany). Movies (each with 200 images) of polystyrene particle transport were recorded from at least six different areas for each trachea at 12 Hz frame rate and a resolution of 1280 × 1024 pixels. Particle transport speed was determined by tracking individual particles and manually checking each recorded track using Image-Pro® Plus 6.0 (Medium Cybernetics, Inc., Bethesda, MD, USA). The mean particle transport speed was calculated for each experiment. Movies (each with 1000 images) of cilia motion were recorded at 100 Hz frame rate and 640 × 480 pixels). The ciliary beat frequency was determined by Fourier transformation of grey level changes over time using an in-house developed software written in Mathlab (Mathworks, Natick, MA, USA). For visualization of ciliary beat frequency, the dominant frequency, i.e. the frequency with the highest amplitude, was identified for every pixel in the movie and color-coded. Movies were recorded from at least six different areas for each trachea. The ciliary beat frequency of a minimum of 10 ciliated cells was measured in every movie and the mean frequency from these cells was calculated. To increase ciliary beat frequency or cilia-driven particle transport, ATP (10 μM) was applied as positive control.

Statistical analysis

All ex vivo experiments were carried out at least three times. Quantitative RT-PCR data are presented as mean ± SEM. The data sets were analyzed using paired-sample Wilcoxon signed-rank test in GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). P values < 0.05 were considered statistically significant.

Mucus staining in tracheal whole mounts

Tracheae were incubated in 1 ml HEPES-Ringer solution at 30 °C; 1 μl of a 1:1 mix of wheat germ agglutinin (WGA) and Ulex europaeus agglutinin (UEA-1) was added (each 1 μg/ml). WGA stains N-acetyl-D-glucosamine and sialic acid residues, whereas UEA-1 has an affinity for L-fucose, all of which are carbohydrate residues present in mucins [48, 49]. In addition, WGA labels ciliated cells [50]. The staining was imaged with an AxioMR camera and an Achroplan 40×/0.8 W objective with a resolution of 1388 × 1040 pixels.

Further information on the determination of cytokine levels and cell viability in vitro, CBNP aerosol generation and exposure of rats, oxidative Comet-Assay, histopathology of the rat lungs, particle suspensions in cell culture medium, preparation and culture conditions of intrapulmonary airways, qualitative RT-PCR, macroscopic analysis, scanning electron microscopy and individual statistics are provided in Additional file 5.

Results

Characterization of CBNP and their suspensions

All of the tested nanoparticles had similar hydrodynamic diameters and ζ-potentials in medium (Table 1 and Additional file 1). P90 without PAHs had a mean primary particle size of 16.5 nm (Table 1 and Additional file 1). The minimal mass loss at the final temperature of 800 °C indicated that P90 had negligible volatile compounds on the surface. The coating of P90 nanoparticles with BaP or 9NA reduced the specific surface area about one third. P90-BaP and P90-9NA had almost the same mass loss, indicating a similar PAH proportion on the CBNP surface (Table 1 and Additional file 2A).

Table 1 Characteristics of dry and suspended CBNP
Full size table

AS-PAH exhibited a slightly larger specific surface area and mass loss compared with the coated P90 nanoparticles, and AS-PAH without PAHs showed a slightly smaller mean primary particle size than uncoated P90 (Table 1 and Additional file 1).

The thermogravimetric (TG) analysis of AS-PAH indicated a two-stage thermal desorption of surface components (Additional file 2B). The first stage ended at approximately 240 °C and mainly included PAHs (Additional file 2C). Because of possible defragmentation, the exact PAH content cannot be determined, but a minimal PAH content of approximately 11% was calculated via TG curve correlating with the mass loss at 240 °C (Additional file 2C). In the second stage, hydrogen, methane, water, acetylene and carbon dioxide were mainly released (Additional file 2D).

With combined TG/MS analysis, we detected PAHs with a maximal mass-to-charge ratio of 202 (Additional file 2E). Due to the possible condensation of high weight PAHs with a boiling point with more than 400 °C before MS inlet, we extracted the PAHs from AS-PAH and analyzed them with gas chromatographic (GC)/MS. The results are reported in Table 2 and Additional file 2 F. Endotoxins were not detected in any CBNP test preparation.

Table 2 Identified PAHs extracted from the AS-PAH surface
Full size table

Analysis of CBNP effects in vitro

The in vitro effects of CBNP depended on the cell line

A549 cells are widely accepted as a general model for lung epithelium. ROS formation was increased in these cells by P90 and AS-PAH, but not by P90-BaP or P90-9NA (Table 3). The highest ROS levels were detected after treatment with AS-PAH at both dose levels (Table 3), although P90 was the only particle that induced mRNA expression of IL-8 (Table 3).

Table 3 In vitro results of ROS, IL-8 mRNA expression and TEER measurement after exposure to CBNP
Full size table

16HBE14o- cells are regarded as model for bronchial epithelial cells. In these cells, all CBNP induced ROS formation at 50 μg/ml, but only P90-9NA increased IL-8 mRNA expression. Calu-3 cells are models for both bronchial epithelial cells and epithelial barrier function. In these cells, P90-BaP and AS-PAH induced IL-8 mRNA expression; only AS-PAH reduced TEER (Table 3). AS-PAH-induced IL-8 protein release was significantly increased compared to that following P90 exposure (Additional file 6A). IL-6 protein was significantly increased in the supernatant after exposure to 50 μg/ml P90-BaP, and following exposure to both concentrations of AS-PAH (Additional file 6B). Cell viability was not significantly affected by the tested CBNP at either concentration (Additional file 6C).

In vivo nose-only inhalation study in rats

CBNP aerosol characterization

Aerosol concentrations and mass median aerodynamic diameters (MMADs) are summarized in Additional file 7. The mean concentrations were close to the target concentration (6 mg/m3) for all aerosols, and all MMADs were below 3 μm.

Only AS-PAH increased the relative lung weights and induced a moderate inflammatory response

On day 1 after cessation of exposure, relative lung weights were significantly increased only in the AS-PAH group (Fig. 1), with absolute lung wet weights increased in both the AS-PAH and P90-BaP inhalation group (Additional file 8). After a 14 day recovery period, the only effect seen in the inhalation groups was a slight decrease in the terminal body weight in the AS-PAH group (Fig. 1).

Fig. 1
figure 1

P90 and AS-PAH induced an inflammatory response in vivo. The diagrams show relative lung weights (a), the amount of total cells (b) and results of differential cell counts in BAL fluid (c-e) after nose-only inhalation. Data are mean ± SD; n = 10 results of relative lung weight; n = 5 for total cell count and differential cell counts; *p < 0.05 and **p < 0.01 CBNP exposure compared to clean air control, analyzed by analysis of variance and Dunnett’s test; PMNs = polymorphonuclear cells, D1 = day 1 post-exposure, D14 = day 14 post-exposure

Full size image

On day 1 post-exposure, there was a statistically significant increase in polymorphonuclear granulocyte numbers in the animals exposed to P90 and AS-PAH compared to the clean air control group (Fig. 1). In AS-PAH treated animals, numbers of polymorphonuclear granulocytes were still moderately increased on day 14 compared to clean air treated animals, indicating the presence of a mild chronic inflammatory response (Fig. 1). None of the tested CBNP influenced LDH, β-glucuronidase activity, or total protein levels in BAL fluid (Additional file 9A), and none induced oxidative DNA damage in BAL cells (Additional file 9B).

CBNP exposure induced very slight histological alterations (Additional file 10). However, only AS-PAH induced bronchiolo-alveolar hyperplasia, observed in two of five animals on day 14 post-exposure (Additional file 10).

Ex vivo airway models

As the in vivo experiments did not specifically address airway epithelial function but in vitro experiments indicated that airway epithelial cells are sensitive to CBNP effects, we examined the particle effects on explanted murine airways.

Only AS-PAH caused a pro-inflammatory response in the tracheal epithelium

Compared to medium controls, only AS-PAH significantly increased the mRNA expression of pro-inflammatory IL-6 (30 μg/ml), and of keratinocyte chemoattractant (KC), the murine homologue of human IL-8) (Table 4). In contrast, P90-BaP and P90-9NA decreased IL-6 mRNA expression at 30 μg/ml (Table 4). No increase of KC or IL-6 mRNA was detected in the intrapulmonary airways, indicating that the effects observed are region specific (Additional file 11).

Table 4 Results of mRNA expression in tracheal epithelial cells after CBNP exposure
Full size table

All PAH containing CBNP induced Cyp-expression but none of the CBNP induced mRNA for indicators of oxidative stress in tracheal epithelial cells

We analyzed the mRNA expression of the cytochrome P450 enzymes Cyp1A1 and Cyp1B1 as indicators of PAH metabolism, and of Gpx3 and Gr as indicators of oxidative stress.

All PAH-containing CBNP induced Cyp1a1 and Cyp1b1 mRNA in the tracheal epithelium (Table 4). The most potent CBNP was AS-PAH, followed by P90-BaP. P90-9NA only induced Cyp1a1 and Cyp1b1 mRNA expression at 30 μg/ml. In contrast, the uncoated P90 nanoparticles did not induce Cyp1a1 mRNA expression, and significantly decreased Cyp1b1 mRNA expression compared to medium controls in tracheal epithelial cells (Table 4). None of the CBNP increased the mRNA expression of Gpx3 or Gr. In intrapulmonary airways PAH-containing CBNP induced a similar expression pattern of Cyp1a1 mRNA compared to the tracheal epithelium; no increase of mRNAs for anti-oxidative enzymes was detected (Additional file 11).

Since the mRNA data of Cyp-expression indicated that the CBNP affect airway epithelial cells and to detect changes in epithelial function, we assessed their impact on cilia-driven transport.

Only P90 forms microscopically visible agglomerates; these bind to mucus and interact with ciliated cells

On microscopic examination of tracheae, visible agglomerates were observed on the airway epithelium after 24 h of incubation with P90 at 10 μg/ml and 30 μg/ml (Additional file 12A). These agglomerates were bound either to mucus on the epithelium or directly to cilia of ciliated cells (Fig. 2a and b and Additional files 13 and 14). None of the PAH-containing CBNP showed microscopically visible agglomerates at either tested concentration (Additional file 12A).

Fig. 2
figure 2

PAH altered P90 induced effects on mucociliary clearance in the ex vivo murine trachea. a Mucus on the epithelium was stained with a mixture of wheat germ agglutinin (WGA) and Ulex europaeus agglutinin-1 (UEA-1) after exposure to P90. White arrows indicate mucus structures associated with P90 agglomerates. b P90 agglomerates attached to cilia of ciliated epithelial cells. Red arrows indicate P90 agglomerates. c, d Ciliary beat frequency (c) and particle transport speed (d) after exposure to 10 μg/ml P90. e-h Ciliary beat frequency (e, f) and particle transport speed (g, h) after exposure to 10 μg/ml P90-BaP or P90-9NA. i, j Ciliary beat frequency (i) and particle transport speed (j) after exposure to 10 μg/ml AS-PAH. k-n Particle transport speed after exposure to 30 μg/ml P90 (k), P90-BaP (l), P90-9NA (m) and AS-PAH (n). c, e, f, i Each point represents the mean ciliary beat frequency of at least 50 ciliated cells measured at eight different tracheal regions of each animal. d, g, h, k-n Each point represents the mean particle transport speed of added polystyrene particles measured at eight different tracheal regions of each mouse. A minimum of n = 5 animals were analyzed. The exposure time was 24 h for all experiments. p < 0.05 was considered statistically significant. The medium controls were compared to CBNP exposure analyzed by Wilcoxon signed-rank test

Full size image

Additional file 13: P90 agglomerates attached to cilia of ciliated cells after incubation with 10 μg/mlP90. The movie shows cilia movement and attached P90 agglomerates on cilia of tracheal epithelium after 24 h exposure to 10 μg/ml P90. The movie was recorded with 100 Hz and a resolution of 640 × 480 pixels. The image sequence contains 1000 images. (WMV 11853 kb)

Additional file 14: P90 agglomerates attached to cilia of ciliated cells after incubation with 30 μg/ml P90. The movie shows the cilia movement and bound P90 agglomerates on the cilia of tracheal epithelium after 24 h exposure to 30 μg/ml P90. The movie was recorded with 100 Hz, a resolution of 640 × 480 pixels and contains 1000 images. (WMV 11658 kb)

At 10 μg/ml, P90 agglomerates increased ciliary beat frequency but mucus reduced particle transport speed

Compared to medium control, P90 at 10 μg/ml increased mean ciliary beat frequency (Fig. 2c), although it did not increase the mean of cilia-driven particle transport speed (Fig. 2d). Cells with bound agglomerates exhibited a higher ciliary beat frequency compared to cells without visible agglomerates (Additional file 12B and C). Furthermore, particle transport speed was reduced in areas with mucus and increased in areas without mucus compared to medium control (Additional file 12D). Incubation with P90 at a concentration of 1 μg/ml did not result in formation of agglomerates, and therefore did not increase ciliary beat frequency (Additional files 12A and 15A). However, this concentration was sufficient to increase mucus (Additional files 15B and C), and consequently to reduce particle transport speed (Additional file 15D).

At 10 μg/ml, PAH-coated P90 did not increase ciliary beat frequency but differently influenced mucus release and particle transport speed

As expected from the inability to form agglomerates, neither P90-BaP nor P90-9NA increased ciliary beat frequency (Fig. 2e and f). Incubation with P90-BaP increased amounts of mucus on the epithelial cells (Additional files 16 and 17), with a consequent reduced particle transport speed compared to control (Fig. 2g and h). In contrast to P90 at 10 μg/ml, we observed dead cells on the epithelium during the experiments with both coated particles (Additional files 16, 17 and 18).

At 10 μg/ml, AS-PAH increased ciliary beat frequency and mucus release but reduced particle transport speed

Although AS-PAH did not form agglomerates, it increased ciliary beat frequency and resulted in mucus release (Fig. 2i, and Additional files 12A and 19). Compared to control, AS-PAH reduced particle transport speed (Fig. 2j), and, as with both coated particles, we observed dead cells on the epithelium (Additional file 19).

At 30 μg/ml, all particles resulted in reduced particle transport speed

At 30 μg/ml, none of the particles increased ciliary beat frequency but all reduced particle transport speed (Fig. 2k to n and Additional file 20). All particles increased mucus, and dead cells were visible on the epithelium (Additional files 16, 17, 18 and 19).

PAH-containing particles induced apoptosis in tracheal epithelial cells

At 10 μg/ml, P90 did not increase cell death (Fig. 3a and b). In contrast, at this concentration all PAH-containing particles increased cell death, with inducing apoptosis (Fig. 3a) and P90-9NA and AS-PAH also increasing the number of necrotic cells (Fig. 3b). At 30 μg/ml, all particles increased cell death, with the PAH-coated particles inducing both necrosis and apoptosis, whereas P90 only increased necrosis (Fig. 3a and b). Of note, necrotic and apoptotic cells represented no more than 2% of all counted airway epithelial cells, suggesting that this small amount of damage might not be detectable with common assays.

Fig. 3
figure 3

Surface PAHs increased epithelial toxicity of CBNP in the ex vivo murine tracheal model. The diagrams show the quantification of apoptotic (a) and necrotic (b) epithelial cell numbers. Data represent the total number of necrotic and apoptotic cells counted in whole mount preparation after 24 h exposure to CBNP compared to medium controls. All data are mean ± SEM. n = 5–11, *p < 0.05 and **p < 0.01, CBNP compared to medium controls analyzed by Wilcoxon signed-rank test

Full size image

Discussion

Our results suggest that the biological effect of PAH-coating is a combination of specific surface area and PAH-specific effects.

In our study, we used four CBNP: P90, P90 coated with BaP (P90-BaP), P90 coated with 9NA (P90-9NA), and, to model nanoparticles that acquire PAH during synthesis, a soot derived from acetylene combustion that contains various PAHs (AS-PAH). This allowed us to examine how PAH coating changes the behavior of the P90 nanoparticle in various test systems. These particles were tested in vitro, ex vivo and in vivo.

Particle characteristics

Nanoparticle reactivity is determined by the surface reactivity, including the nanoparticle characteristics: size, shape, solubility, surface area, and chemical composition [2, 5, 8, 9, 51, 52]. All particles that we used had similar primary particle size, shape, and hydrodynamic diameters and ζ-potential in medium. An equal solubility was accomplished by adding protein, resulting in negative ζ-potential at physiological pH-value. Thus, any differences observed are attributable to the surface area or surface chemical composition of the CBNP. Coating of P90 with either PAH reduced its surface area from 302 m2/g to 91 m2/g; since the effects of P90 in biological systems are attributed to its high surface area, this reduction would be expected to reduce the observed biological effects [1, 10].

BaP is considered a tumorigenic reference PAH, with well characterized effects, including induction of ROS formation, IL-8 release and apoptosis [6, 15, 53–57]. It is metabolized by Cyp1A1 and 1B1, and has been shown to upregulate these enzymes both on mRNA and protein levels [23, 58]. Thus, increases in Cyp1a1 and 1b1 mRNA indicate that this PAH is bioavailable in cells. PAH with 4 and more aromatic rings and specific structural features (Bay- or Fjord-region) are strong Cyp inducers and considered to be tumorigenic [15, 59]. Since 9NA is composed of only three aromatic rings, it is less toxic than BaP and considered as weak Cyp inducer [15, 43] as confirmed by our Cyp1a1 and Cyp1b1 mRNA expression results.

Since it is possible that coating of CBNP may result in a different distribution of PAH compared to particles that acquire PAH during synthesis, we also used AS-PAH synthesized from acetylene combustion as a test compound [44, 60]. Since AS-PAH has a similar surface area, shape, size and solubility compared to PAH-coated P90, the different effects of these particles observed in the biological systems are likely the result of its different PAH composition [61, 62]. The AS-PAH that we synthesized contained a mixture of at least 17 PAH with 2–7 aromatic rings that could be removed from the particle with organic solvents, indicating that these PAH are on the surface of the particle. Several of the identified PAH are predicted to be metabolized by Cyp1A1 and 1B1 and induce their mRNA. Thus, by determining the mRNA expression of both enzymes allowed us to determine if the PAHs from AS-PAH are bioavailable. The presence of PAHs with 5 or more aromatic rings predict that, compared to BaP, the PAH mixture of AS-PAH would be more toxic [15, 63]. For example, compared with BaP the 5-ring component cyclopenta[cd]pyrene induced the same mutation mechanism [64], a stronger lung tumorigenic response in A/J mice [65] and was 6.9 ± 4.2-fold more mutagenic in vitro [43]. In addition, PAH-mixtures are often more toxic than would be expected by simple addition of the individual PAH toxicities [65, 66]. Thus, when not bound to CBNP the PAH mixture from AS-PAH is likely to be more toxic compared to BaP. Since the relative in vivo effects of PAHs depend on their bioavailability, their clinical impact cannot be fully predicted without appropriately designed and conducted studies, such as those we report here.

When predicting the behavior of PAH-coated versus uncoated nanoparticles in biological systems, three different scenarios are possible. First, the reduction of the surface area could reduce the biological effects of CBNP, and differences in the PAHs would therefore not have an impact. Second, the PAH content could increase the biological effects of CBNP due to the toxicity of PAH – and so irrespective of the particle’s surface area. A third possibility is that toxicity could be decreased in some cell types due to the reduced surface area, but increased in other cell types due to PAH toxicity.

Biological effects of uncoated and PAH-coated CBNP

Supporting the hypothesis that a reduced surface area reduces the biological effects of CBNP [1, 10, 67], the coating of P90 with BaP prevented the P90-induced increase of the neutrophil attracting cytokine IL8 mRNA in A549 cells. As the high surface area of P90 is strongly associated with induction of oxidative stress, the reduced biological effect can be explained by the reduced ROS release that we observed with P90-BaP and P90-9NA in A549 cells compared to uncoated P90. This reduced biological effect is also supported by our observation that P90, and not P90-BaP, led to a transient increase in granulocyte influx in the in vivo experiment. This transient increase in granulocytes without changes of total cell number has previously been observed [68, 69]. The mechanism for the reduced number of macrophages is not known and would be an interesting area for future research. However, these results clearly demonstrate that surface area can be an important factor of CBNP effects in biological systems.

However, other results support the theory that PAH can increase the effects of CBNP [29]. Firstly, we found that P90-BaP, P90-9NA and AS-PAH induced apoptosis in tracheal epithelial cells ex vivo, whereas P90 did not. This is consistent with previous reports describing apoptosis induction by PAH [54, 56, 57, 70]. Secondly, PAH-coated P90 and AS-PAH strongly induced Cyp mRNA expression. Cyp1a1 and Cyp1b1 mRNA are known to be induced by PAH in a subgroup of airway epithelial cells [71], and so their induction in both the trachea and intrapulmonary airways demonstrate that the PAH are biologically active. Interestingly, the assumed differences between P90-9NA, P90-BaP and AS-PAH are also reflected in the level of induction of Cyp1a1 and Cyp1b1 mRNA, in that P90-9NA resulted in the least induction, followed by P90-BaP, with the strongest induction by AS-PAH. Finally, AS-PAH was the only CBNP to reduce TEER in vitro, to increase BAL granulocyte content 14 days after the last application, and induce both histological changes in vivo and inflammatory mediator mRNA expression (KC and IL-6) ex vivo. Furthermore, AS-PAH had the highest apoptosis rate in tracheal epithelium ex vivo.

Our data therefore suggest that the overall biological impact of a PAH depends on the relative contribution of surface area reduction and PAH-induced toxicity, that is, in turn, influenced by the biological system. This is exemplified by cilia-driven particle transport speed, which is influenced by ciliary beat frequency, mucus release and epithelial cell death.

In the ex vivo trachea, P90 was the only particle to form aggregates. These aggregates bound to ciliated cells and increased ciliary beat frequency. Furthermore, microscopically visible nanoparticle agglomerates have been shown to increase ciliary beat frequency in the murine trachea [72]. A similar effect has been observed in the bovine trachea where polystyrene particles >200 nm in diameter that attach to cilia increase ciliary beat frequency due to mechanical stimulation of axonema possibly involving second messengers such as cAMP or cGMP [73], both of which are known to increase ciliary beat frequency [74]. In addition, mechanical stimulation of cilia triggers Ca2+ influx, with a consequent increase in ciliary beat frequency [75]. Coating of P90 with PAHs prevented aggregate formation and consequently neither P90-BaP nor P90-9NA impact ciliary beat frequency. Thus, this shows that PAH coating of P90 reduced its effects on a biological system by changing its surface properties and not by a specific PAH toxicity. However, we detected an increase in epithelial cell apoptosis after application of P90-BaP and P90-9NA compared to P90. This increase in apoptosis together with the induction of Cyp enzymes can directly be ascribed to PAH toxicity [70].

AS-PAH increased ciliary beat frequency without forming microscopically visible agglomerates. Interestingly, fluoranthene, a PAH that we detected on the surface of AS-PAH, has previously been shown to induce a persistent increase in Ca2+ in Calu-3 cells, whereas BaP and anthracene did not [76]. Since an increase in intracellular Ca2+ is known to increase ciliary beat frequency [74], it is possible that fluoranthene is directly responsible for the increased ciliary beat frequency. Despite increasing ciliary beat frequency there was a marked reduction in particle transport speed, possibly due to increased apoptosis and mucus release.

Previous research has shown that despite being bound to the surface of CBNP, PAHs can be bioavailable [77]. Our data confirm that PAH bound to CBNP exerts biological effects in epithelial cells, as demonstrated by Cyp1a1 mRNA induction. Cyp1a1 mRNA expression is a very sensitive parameter for detecting biologically active PAHs [78]. The induction of Cyp1a1 mRNA is triggered by binding of PAH to the aryl hydrocarbon receptor (AhR) that then translocates into the cell nucleus, and interacts with AhR nuclear translocator [79]. This complex then induces Cyp1a1 mRNA expression by binding to xenobiotic response elements [79]. In low concentrations, AhR activation suppresses the activity of the transcription factor p65 [80], which is known to induce the mRNA expression of IL-6 and IL-8 [81, 82]. We also observed a small but significant decrease in IL-6 mRNA expression in the epithelium of explanted tracheae, possibly due to AhR activation. At higher concentrations, PAHs can lead to IL-6 and IL-8 mRNA expression [80] – as we observed with AS-PAH. In general, AS-PAH had more effects than the PAH-coated CBNP, probably due to the composition of PAH present on the particle’s surface. As discussed above, the PAH fluoranthene induces prolonged increase in intracellular Ca2+ in Calu-3, whereas BaP and anthracene do not [76]. Yamaguchi et al. also observed an increase of intracellular Ca2+ that was independent from AhR [83], indicating that PAH have additional activities apart from the classical AhR pathway. Identification of the specific PAH and/or PAH mixture that is responsible for the increased effects of AS-PAH would require additional research, although fluoranthene and compounds such as cyclopenta[cd]pyrene are possible candidates.

We have shown that AS-PAH exerts more toxic effects than P90 despite its reduced surface area. We attribute this to the composition of the surface PAHs. The relative toxicity of P90-9NA and P90-BaP, and the resultant biological effect, depended on the test system used.

Choice of test systems

In general, cell lines can give valuable information if the test substance is interfering with basal cell functions present in all cells. However, if cell lines lack specific pathways that are important for toxic effects, their value for predicting in vivo toxicity is limited [84].

The prediction of an in vivo effect based on results obtained in a single cell line is made more challenging, since both changes in surface area and direct PAH toxicity impact the overall effect of particles. This may explain why we had different results in terms of IL-8 mRNA production in different cell lines. The reason for these differences was most likely that some cell lines were more sensitive to the toxic effects of the PAHs, whereas others were more sensitive to changes in surface area. An in vivo experiment in which all target cell types are present is therefore in principle better suited to detect effects [84]. However, in a single in vivo experiment, only a limited number of parameters can be determined. The readouts predetermined in the OECD experiment focus on inflammation and cell death. They do not address effects on mucociliary clearance. It should be noted, however that sustained impairment of mucociliary clearance can have substantial health effects [85–88] that are missed in animal models by focusing solely on inflammation and cell death. In principle, in vivo experiments can be designed to also include these parameters. However, this would be time consuming and cost intensive. The strength of short-term organ culture models is that they can be adapted to screen for specific organ functions that are not routinely examined in standardized in vivo experiments. This was demonstrated by using our ex vivo trachea model that allowed examining the complex interplay between mucus production, ciliary beating and cell death [72, 89].

Conclusions

Using a range of different test systems our results demonstrate that the biological effect of CBNP is determined by a combination of specific surface area and the composition of the surface-bound PAH, and varies in different target cells. Specifically, AS-PAH exerted more toxic effects than P90 despite its reduced surface area. We attribute this to the composition of the surface PAHs. However, the relative toxicity of P90-9NA and P90-BaP depended on the test system used.

References

  1. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, et al. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect. 2006;114:328–33.

    Article  PubMed  Google Scholar 

  2. Sahu D, Kannan GM, Vijayaraghavan R. Carbon black particle exhibits size dependent toxicity in human monocytes. Int J Inflam. 2014;2014:1–10.

    Article  Google Scholar 

  3. Marzaioli V, Aguilar-Pimentel JA, Weichenmeier I, Luxenhofer G, Wiemann M, Landsiedel R, et al. Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties. Int J Nanomedicine. 2014;9:2815–32.

    PubMed  PubMed Central  Google Scholar 

  4. Cheng WJ, Rong Y, Shi TM, Zhou T, Liu YW, Chen WH. Size-dependent biological effects on vascular endothelial cells induced by different particulate matters. J Huazhong Univ Sci Technolog Med Sci. 2014;34:314–21.

    Article  CAS  PubMed  Google Scholar 

  5. Braakhuis HM, Park MV, Gosens I, De Jong WH, Cassee FR. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol. 2014;11:18.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ma JYC, Ma JKH. The dual effect of the particulate and organic components of diesel exhaust particles on the alteration of pulmonary immune/inflammatory responses and metabolic enzymes. J Environ Sci Health C. 2002;20:117–47.

    Article  Google Scholar 

  7. Gatoo MA, Naseem S, Arfat MY, Dar AM, Qasim K, Zubair S. Physicochemical properties of nanomaterials: implication in associated toxic manifestations. Biomed Res Int. 2014;2014:498420.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Shin SW, Song IH, Um SH. Role of physicochemical properties in nanoparticle toxicity. Nanomaterials. 2015;5:1351–65.

    Article  CAS  Google Scholar 

  9. Stoeger T, Schmid O, Takenaka S, Schulz H. Inflammatory response to TiO2 and carbonaceous particles scales best with BET surface area. Environ Health Perspect. 2007;115:A290–1.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Schmid O, Stoeger T. Surface area is the biologically most effective dose metric for acute nanoparticle toxicity in the lung. J Aerosol Sci. 2016;99:133–43.

    Article  CAS  Google Scholar 

  11. Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA, et al. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology. 2009;260:142–9.

    Article  CAS  PubMed  Google Scholar 

  12. Vesterdal LK, Mikkelsen L, Folkmann JK, Sheykhzade M, Cao Y, Roursgaard M, et al. Carbon black nanoparticles and vascular dysfunction in cultured endothelial cells and artery segments. Toxicol Lett. 2012;214:19–26.

    Article  CAS  PubMed  Google Scholar 

  13. Ma-Hock L, Strauss V, Treumann S, Kuttler K, Wohlleben W, Hofmann T, et al. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol. 2013;10:23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhang R, Dai Y, Zhang X, Niu Y, Meng T, Li Y, et al. Reduced pulmonary function and increased pro-inflammatory cytokines in nanoscale carbon black-exposed workers. Part Fibre Toxicol. 2014;11:73.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Boström CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect. 2002;110:451–88.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kong HT, Xia K, Pan L, Zhang JC, Luo Y, Zhang Y, et al. Autophagy and lysosomal dysfunction: a new insight into mechanism of synergistic pulmonary toxicity of carbon black-metal ions co-exposure. Carbon. 2017;111:322–33.

    Article  CAS  Google Scholar 

  17. Valavanidis A, Fiotakis K, Vlachogianni T. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008;26:339–62.

    Article  CAS  PubMed  Google Scholar 

  18. Lighty JS, Veranth JM, Sarofim AF. Combustion aerosols: factors governing their size and composition and implications to human health. J Air Waste Manag Assoc. 2000;50:1565–618.

    Article  CAS  PubMed  Google Scholar 

  19. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823–39.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Bonvallot V, Baeza-Squiban A, Baulig A, Brulant S, Boland S, Muzeau F, et al. Organic compounds from diesel exhaust particles elicit a proinflammatory response in human airway epithelial cells and induce cytochrome p450 1A1 expression. Am J Respir Cell Mol Biol. 2001;25:515–21.

    Article  CAS  PubMed  Google Scholar 

  21. World Health Organization. Air quality guidelines for Europe. WHO Reg Publ Eur Ser. 2000;V-X:1–273.

    Google Scholar 

  22. Shimada T, Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 2004;95:1–6.

    Article  CAS  PubMed  Google Scholar 

  23. Baird WM, Hooven LA, Mahadevan B. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen. 2005;45:106–14.

    Article  CAS  PubMed  Google Scholar 

  24. Dasenbrock C, Peters L, Creutzenberg O, Heinrich U. The carcinogenic potency of carbon particles with and without PAH after repeated intratracheal administration in the rat. Toxicol Lett. 1996;88:15–21.

    Article  CAS  PubMed  Google Scholar 

  25. Goulaouic S, Foucaud L, Bennasroune A, Laval-Gilly P, Falla J. Effect of polycyclic aromatic hydrocarbons and carbon black particles on pro-inflammatory cytokine secretion: impact of PAH coating onto particles. J Immunotoxicol. 2008;5:337–45.

    Article  CAS  PubMed  Google Scholar 

  26. Mroz RM, Schins RP, Li H, Drost EM, Macnee W, Donaldson K. Nanoparticle carbon black driven DNA damage induces growth arrest and AP-1 and NFkappaB DNA binding in lung epithelial A549 cell line. J Physiol Pharmacol. 2007;58 Suppl 5:461–70.

    PubMed  Google Scholar 

  27. Mroz RM, Schins RP, Li H, Jimenez LA, Drost EM, Holownia A, et al. Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways. Eur Respir J. 2008;31:241–51.

    Article  CAS  PubMed  Google Scholar 

  28. Borm PJA, Cakmak G, Jermann E, Weishaupt C, Kempers P, van Schooten FJ, et al. Formation of PAH-DNA adducts after in vivo and vitro exposure of rats and lung cells to different commercial carbon blacks. Toxicol Appl Pharmacol. 2005;205:157–67.

    Article  CAS  PubMed  Google Scholar 

  29. Chin BY, Choi ME, Burdick MD, Strieter RM, Risby TH, Choi AMK. Induction of apoptosis by particulate matter: role of TNF-alpha and MAPK. Am J Physiol Lung Cell Mol Physiol. 1998;275:L942–9.

    CAS  Google Scholar 

  30. Delfino RJ. Epidemiologic evidence for asthma and exposure to air toxics: linkages between occupational, indoor, and community air pollution research. Environ Health Perspect. 2002;110 Suppl 4:573–89.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Balmes JR. How does diesel exhaust impact asthma? Thorax. 2011;66:4–6.

    Article  PubMed  Google Scholar 

  32. OECD. Guideline for Testing of Chemicals, Test Guideline 412. Repeated Dose Inhalation Toxicity: 28-day or 14-day Study. 1981; http://www.nikkakyo.org/ontai/merumaga/Challenge/OECD/TG_412.pdf. Accessed on 21th December 2016.

  33. Sager TM, Castranova V. Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part Fibre Toxicol. 2009;6:15.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Landsiedel R, Ma-Hock L, Kroll A, Hahn D, Schnekenburger J, Wiench K, et al. Testing metal-oxide nanomaterials for human safety. Adv Mater. 2010;22:2601–27.

    Article  CAS  PubMed  Google Scholar 

  35. Verma N, Pink M, Rettenmeier AW, Schmitz-Spanke S. Review on proteomic analyses of benzo[a]pyrene toxicity. Proteomics. 2012;12:1731–55.

    Article  CAS  PubMed  Google Scholar 

  36. Boysen G, Hecht SS. Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat Res. 2003;543:17–30.

    Article  CAS  PubMed  Google Scholar 

  37. Shen YM, Troxel AB, Vedantam S, Penning TM, Field J. Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection. Chem Res Toxicol. 2006;19:1441–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Zhang LJ, Bao Y, Li J. Nuclear respiratory factor-1 is involved in mitochondrial dysfunction induced by benzo(a)pyrene in human bronchial epithelial cells. Basic Clin Pharmacol Toxicol. 2011;109:115–22.

    Article  CAS  PubMed  Google Scholar 

  39. Ovrevik J, Arlt VM, Oya E, Nagy E, Mollerup S, Phillips DH, et al. Differential effects of nitro-PAHs and amino-PAHs on cytokine and chemokine responses in human bronchial epithelial BEAS-2B cells. Toxicol Appl Pharmacol. 2010;242:270–80.

    Article  CAS  PubMed  Google Scholar 

  40. Harrigan JA, McGarrigle BP, Sutter TR, Olson JR. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene. Toxicol In Vitro. 2006;20:426–38.

    Article  CAS  PubMed  Google Scholar 

  41. Fu PP, Von Tungeln LS, Chou MW. Metabolism of 9-nitroanthracene by rat liver microsomes: identification and mutagenicity of metabolites. Carcinogenesis. 1985;6:753–7.

    Article  CAS  PubMed  Google Scholar 

  42. Fu PP, Heflich RH, Von Tungeln LS, Yang DT, Fifer EK, Beland FA. Effect of the nitro group conformation on the rat liver microsomal metabolism and bacterial mutagenicity of 2- and 9-nitroanthracene. Carcinogenesis. 1986;7:1819–27.

    Article  CAS  PubMed  Google Scholar 

  43. Durant JL, Busby Jr WF, Lafleur AL, Penman BW, Crespi CL. Human cell mutagenicity of oxygenated, nitrated and unsubstituted polycyclic aromatic hydrocarbons associated with urban aerosols. Mutat Res. 1996;371:123–57.

    Article  CAS  PubMed  Google Scholar 

  44. Stroebele MR, Bockhorn H. Effects of synthesis conditions on the content of polycyclic aromatic hydrocarbons on the surface of carbon black nanoparticles. Proceedings of the European Combustion Meeting. 2013:Paper P5-52.

  45. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1994;10:38–47.

    Article  CAS  PubMed  Google Scholar 

  46. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245–50.

    Article  CAS  PubMed  Google Scholar 

  47. Zehethofer N, Bermbach S, Hagner S, Garn H, Muller J, Goldmann T, et al. Lipid analysis of airway epithelial cells for studying respiratory diseases. Chromatographia. 2015;78:403–13.

    Article  CAS  PubMed  Google Scholar 

  48. Crouzier T, Beckwitt CH, Ribbeck K. Mucin multilayers assembled through sugar-lectin interactions. Biomacromolecules. 2012;13:3401–8.

    Article  CAS  PubMed  Google Scholar 

  49. Kawano K, Uehara F, Sameshima M, Ohba N. Application of lectins for detection of goblet cell carbohydrates of the human conjunctiva. Exp Eye Res. 1984;38:439–47.

    Article  CAS  PubMed  Google Scholar 

  50. Chazotte B. Labeling membrane glycoproteins or glycolipids with fluorescent wheat germ agglutinin. Cold Spring Harb Protoc. 2011;2011:pdb prot5623.

  51. Knaapen AM, Borm PJ, Albrecht C, Schins RP. Inhaled particles and lung cancer. Part A: mechanisms. Int J Cancer. 2004;109:799–809.

    Article  CAS  PubMed  Google Scholar 

  52. Yang H, Liu C, Yang D, Zhang H, Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2009;29:69–78.

    Article  PubMed  Google Scholar 

  53. Podechard N, Lecureur V, Le Ferrec E, Guenon I, Sparfel L, Gilot D, et al. Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation. Toxicol Lett. 2008;177:130–7.

    Article  CAS  PubMed  Google Scholar 

  54. Jyonouchi H. Airway epithelium and apoptosis. Apoptosis. 1999;4:407–17.

    Article  CAS  PubMed  Google Scholar 

  55. Kim KB, Lee BM. Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo(a)pyrene. Cancer Lett. 1997;113:205–12.

    Article  CAS  PubMed  Google Scholar 

  56. Tesfaigzi Y. Roles of apoptosis in airway epithelia. Am J Respir Cell Mol Biol. 2006;34:537–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, et al. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol. 2003;23:255–61.

    Article  CAS  PubMed  Google Scholar 

  58. Tsuji PA, Walle T. Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis. 2006;27:1579–85.

    Article  CAS  PubMed  Google Scholar 

  59. Elovaara E, Mikkola J, Stockmann-Juvala H, Luukkanen L, Keski-Hynnila H, Kostiainen R, et al. Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver. Arch Toxicol. 2007;81:169–82.

    Article  CAS  PubMed  Google Scholar 

  60. Donnet J-B, Bansal RC, Wang M-J. Carbon black - science and technology. Secondth ed. New York - Basel: Marcel Dekker, Inc; 1993.

    Google Scholar 

  61. Schreiber N, Strobele M, Kopf J, Hochscheid R, Kotte E, Weber P, et al. Lung alterations following single or multiple low-dose carbon black nanoparticle aspirations in mice. J Toxicol Environ Health A. 2013;76:1317–32.

    Article  CAS  PubMed  Google Scholar 

  62. Schreiber N, Strobele M, Hochscheid R, Kotte E, Weber P, Bockhorn H, et al. Modifications of carbon black nanoparticle surfaces modulate type II pneumocyte homoeostasis. J Toxicol Environ Health A. 2016;79:153–64.

    Article  CAS  PubMed  Google Scholar 

  63. Moorthy B, Chu C, Carlin DJ. Polycyclic aromatic hydrocarbons: from metabolism to lung cancer. Toxicol Sci. 2015;145:5–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Keohavong P, Melacrinos A, Shukla R. In vitro mutational spectrum of cyclopenta[cd]pyrene in the human HPRT gene. Carcinogenesis. 1995;16:855–60.

    Article  CAS  PubMed  Google Scholar 

  65. Nesnow S, Mass MJ, Ross JA, Galati AJ, Lambert GR, Gennings C, et al. Lung tumorigenic interactions in strain A/J mice of five environmental polycyclic aromatic hydrocarbons. Environ Health Perspect. 1998;106 Suppl 6:1337–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Gibb HJ, Chen CW. Multistage model interpretation of additive and multiplicative carcinogenic effects. Risk Anal. 1986;6:167–70.

    Article  CAS  PubMed  Google Scholar 

  67. Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, et al. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med. 2007;64:609–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Renwick LC, Brown D, Clouter A, Donaldson K. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med. 2004;61:442–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Kyjovska ZO, Jacobsen NR, Saber AT, Bengtson S, Jackson P, Wallin H, et al. DNA damage following pulmonary exposure by instillation to low doses of carbon black (Printex 90) nanoparticles in mice. Environ Mol Mutagen. 2015;56:41–9.

    Article  CAS  PubMed  Google Scholar 

  70. Solhaug A, Refsnes M, Lag M, Schwarze PE, Husoy T, Holme JA. Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells. Carcinogenesis. 2004;25:809–19.

    Article  CAS  PubMed  Google Scholar 

  71. Chang H, Chang LW, Cheng YH, Tsai WT, Tsai MX, Lin PP. Preferential induction of CYP1A1 and CYP1B1 in CCSP-positive cells. Toxicol Sci. 2006;89:205–13.

    Article  CAS  PubMed  Google Scholar 

  72. Bermbach S, Weinhold K, Roeder T, Petersen F, Kugler C, Goldmann T, et al. Mechanisms of cilia-driven transport in the airways in the absence of mucus. Am J Respir Cell Mol Biol. 2014;51:56–67.

    Article  PubMed  Google Scholar 

  73. Navarrette CR, Sisson JH, Nance E, Allen-Gipson D, Hanes J, Wyatt TA. Particulate matter in cigarette smoke increases ciliary axoneme beating through mechanical stimulation. J Aerosol Med Pulm Drug Deliv. 2012;25:159–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Salathe M. Regulation of mammalian ciliary beating. Annu Rev Physiol. 2007;69:401–22.

    Article  CAS  PubMed  Google Scholar 

  75. Li WE, Chen W, Ma YF, Tuo QR, Luo XJ, Zhang T, et al. Methods to measure and analyze ciliary beat activity: Ca2+ influx-mediated cilia mechanosensitivity. Pflugers Arch. 2012;464:671–80.

    Article  CAS  PubMed  Google Scholar 

  76. Ito Y, Son M, Sato S, Ohashi T, Kondo M, Shimokata K, et al. Effects of fluoranthene, a polycyclic aromatic hydrocarbon, on cAMP-dependent anion secretion in human airway epithelia. J Pharmacol Exp Ther. 2004;308:651–7.

    Article  CAS  PubMed  Google Scholar 

  77. Gerde P, Muggenburg BA, Lundborg M, Dahl AR. The rapid alveolar absorption of diesel soot-adsorbed benzo[a]pyrene: bioavailability, metabolism and dosimetry of an inhaled particle-borne carcinogen. Carcinogenesis. 2001;22:741–9.

    Article  CAS  PubMed  Google Scholar 

  78. Totlandsdal AI, Cassee FR, Schwarze P, Refsnes M, Lag M. Diesel exhaust particles induce CYP1A1 and pro-inflammatory responses via differential pathways in human bronchial epithelial cells. Part Fibre Toxicol. 2010;7:41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Rowlands JC, Gustafsson JA. Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol. 1997;27:109–34.

    Article  CAS  PubMed  Google Scholar 

  80. Ovrevik J, Lag M, Lecureur V, Gilot D, Lagadic-Gossmann D, Refsnes M, et al. AhR and Arnt differentially regulate NF-kappaB signaling and chemokine responses in human bronchial epithelial cells. Cell Commun Signal. 2014;12:48.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Kunsch C, Rosen CA. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol. 1993;13:6137–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Libermann TA, Baltimore D. Activation of interleukin-6 gene-expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990;10:2327–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Yamaguchi K, Near R, Shneider A, Cui HL, Ju ST, Sherr DH. Fluoranthene-induced apoptosis in murine T cell hybridomas is independent of the aromatic hydrocarbon receptor. Toxicol Appl Pharmacol. 1996;139:144–52.

    Article  CAS  PubMed  Google Scholar 

  84. Saeidnia S, Manayi A, Abdollahi M. From in vitro experiments to in vivo and clinical studies; pros and cons. Curr Drug Discov Technol. 2015;12:218–24.

    Article  CAS  PubMed  Google Scholar 

  85. Munkholm M, Mortensen J. Mucociliary clearance: pathophysiological aspects. Clin Physiol Funct Imaging. 2014;34:171–7.

    Article  PubMed  Google Scholar 

  86. Hoegger MJ, Fischer AJ, McMenimen JD, Ostedgaard LS, Tucker AJ, Awadalla MA, et al. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science. 2014;345:818–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Livraghi A, Randell SH. Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol Pathol. 2007;35:116–29.

    Article  CAS  PubMed  Google Scholar 

  88. D'Amato G. Environmental urban factors (air pollution and allergens) and the rising trends in allergic respiratory diseases. Allergy. 2002;57 Suppl 72:30–3.

    Article  PubMed  Google Scholar 

  89. König P, Krain B, Krasteva G, Kummer W. Serotonin increases cilia-driven particle transport via an acetylcholine-independent pathway in the mouse trachea. Plos One. 2009;4:e4938.

    Article  PubMed  PubMed Central  Google Scholar 

  90. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. http://monographs.iarc.fr/ENG/Classification/. Accessed on 16th November 2016.

Download references

Acknowledgements

The authors thank Sabine Bartel and Susanne Krauss-Etschmann (Borstel) for providing the 16HBE14o- cells for IL-8 mRNA expression experiments. Additionally, they thank all the participating patients and Dieter C. Gruenert for establishing the 16HBE14o- cell line, and Juliane Artelt (Borstel) and Gudrun Knebel (Lübeck) for expert technical assistance.

David Young, a professional medical writer from Young Medical Communications and Consulting Limited, critically reviewed and language-edited the manuscript prior to submission. This support was funded by the Borstel Research Center and the Universität zu Lübeck.

Funding

This work was funded by the Bundesministerium für Forschung und Bildung (03X0093).

Availability of data and materials

All data that are necessary to understand the theme of the study are included in this published article and its supplementary information files. Additional datasets generated or analyzed during the current study are available from corresponding author on reasonable request.

Authors’ contributions

HF, PK and TH designed the study. MS and HB modified P90, produced the AS-PAH and characterized the CBNP. PG measured and analyzed the aerosol concentration and MMAD. EH performed and analyzed the histological analysis. CZ performed and analyzed the genotoxicological experiments. OC designed and supervised the rat inhalation study. GP was responsible for the generation and characterization of the exposure atmosphere. TT was the veterinarian responsible for the rat inhalation study. KL performed and analyzed the ex vivo studies on tracheal epithelial cells. CB, PK and GH designed the software for the ciliary beat frequency analysis. SS performed and analyzed the ex vivo studies on intrapulmonary bronchioles. TH and JK carried out and analyzed the in vitro experiments (ROS, TEER). IL-8 mRNA expression of 16HBE14o- and Calu-3 cells was analyzed by SW and AJ. AJ determined the IL-6 and IL-8 protein release from Calu-3 cells. JK characterized the CBNP in water and media. KL and PK drafted the manuscript. All authors contributed to the intellectual content of the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable

Ethics approval

The study was performed in accordance with the German animal protection law and approved by the appropriate governmental authorities.

The OECD inhalation study on rats was approved by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit. The ex vivo studies on mouse trachea and intrapulmonary bronchioles were approved by the Ministerium für Landwirtschaft, Umwelt und ländliche Räume des Landes Schleswig-Holstein.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Author notes

    Authors and Affiliations

    1. Institut für Anatomie, Zentrum für medizinische Struktur- und Zellbiologie, Universität zu Lübeck (UzL), Airway Research Center North (ARCN), German Center for Lung Research (DZL), Ratzeburger Allee 160, 23562, Lübeck, Germany

      Karina Lindner & Peter König

    2. Karlsruher Institut für Technologie, Engler-Bunte-Institut, Bereich Verbrennungstechnik, Karlsruhe, Germany

      Michael Ströbele & Henning Bockhorn

    3. Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Experimentelle Pneumologie, Borstel, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Borstel, Germany

      Sandra Schlick, Sina Webering & Heinz Fehrenbach

    4. Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Angeborene Immunität, Borstel, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Borstel, Germany

      André Jenckel & Holger Heine

    5. Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM, Hannover, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany

      Johannes Kopf, Olga Danov, Katherina Sewald, Otto Creutzenberg, Thomas Tillmann, Gerhard Pohlmann, Heinrich Ernst, Christina Ziemann & Tanja Hansen

    6. Institut für Biomedizinische Optik, Universität zu Lübeck (UzL), Lübeck, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Lübeck, Germany

      Christian Buj & Gereon Hüttmann

    Authors
    1. Karina Lindner
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Michael Ströbele
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Sandra Schlick
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Sina Webering
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. André Jenckel
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Johannes Kopf
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Olga Danov
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Katherina Sewald
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Christian Buj
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Otto Creutzenberg
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Thomas Tillmann
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Gerhard Pohlmann
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. Heinrich Ernst
      View author publications

      You can also search for this author in PubMed Google Scholar

    14. Christina Ziemann
      View author publications

      You can also search for this author in PubMed Google Scholar

    15. Gereon Hüttmann
      View author publications

      You can also search for this author in PubMed Google Scholar

    16. Holger Heine
      View author publications

      You can also search for this author in PubMed Google Scholar

    17. Henning Bockhorn
      View author publications

      You can also search for this author in PubMed Google Scholar

    18. Tanja Hansen
      View author publications

      You can also search for this author in PubMed Google Scholar

    19. Peter König
      View author publications

      You can also search for this author in PubMed Google Scholar

    20. Heinz Fehrenbach
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Peter König.

    Additional files

    Additional file 1:

    Electron microscopic images of P90 and AS-PAH. (PDF 428 kb)

    Additional file 2:

    AS-PAH exhibited a less PAH content and a PAH mix compared to the coated P90 nanoparticles. (PDF 308 kb)

    Additional file 3:

    Primer pairs and probes used by quantitative real time RT-PCR. (PDF 75 kb)

    Additional file 4:

    Staining of necrotic and apoptotic cells in the epithelial layer. (PDF 295 kb)

    Additional file 5:

    Supplemental material and methods. (DOCX 31 kb)

    Additional file 6:

    CBNP did not affect the viability of epithelial cells, but P90-BaP and AS-PAH induced cytokine release in vitro. (PDF 91 kb)

    Additional file 7:

    CBNP aerosol concentration and results of Marple impactor measurements used by nose-only inhalation experiments. (PDF 56 kb)

    Additional file 8:

    P90-BaP and AS-PAH increased the lung wet weights after nose-only inhalation. (PDF 67 kb)

    Additional file 9:

    CBNP did not increase enzyme nor total protein levels in BAL and did not induce oxidative DNA-damage in BAL cells after nose-only inhalation. (PDF 80 kb)

    Additional file 10:

    Only AS-PAH induced exposure-related histological alteration in lung tissue after nose-only inhalation. (PDF 72 kb)

    Additional file 11:

    CBNP did not induce oxidative stress or a pro-inflammatory response in intrapulmonary airways. (PDF 106 kb)

    Additional file 12:

    P90 agglomerates increased ciliary beat frequency and released mucus impaired particle transport speed. (PDF 573 kb)

    Additional file 15:

    P90 did not cause agglomerates at 1 μg/ml, but released mucus impaired particle transport. (PDF 1144 kb)

    Additional file 16:

    P90-BaP induced cell death. (PDF 707 kb)

    Additional file 17:

    P90-9NA induced cell death at the higher concentration. (PDF 641 kb)

    Additional file 18:

    P90 induced mucus release. (PDF 1021 kb)

    Additional file 19:

    AS-PAH induced mucus release and cell death. (PDF 639 kb)

    Additional file 20:

    No CBNP increased ciliary beat frequency at 30 μg/ml. (PDF 5594 kb)

    Rights and permissions

    Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Lindner, K., Ströbele, M., Schlick, S. et al. Biological effects of carbon black nanoparticles are changed by surface coating with polycyclic aromatic hydrocarbons. Part Fibre Toxicol 14, 8 (2017). https://doi.org/10.1186/s12989-017-0189-1

    Download citation

    • Received:

    • Accepted:

    • Published:

    • DOI: https://doi.org/10.1186/s12989-017-0189-1

    Keywords

    Particle and Fibre Toxicology

    ISSN: 1743-8977

    Contact us